Politico Future Pulse Newsletter featuring Limax Biosciences
Researchers envision using the gel to attach medical devices to organs and eventually engineering it to dissolve after the body heals from an injury. They’ve also formed a startup, Limax Biosciences, to commercialize their technology. Read More
Biolinq Raises $58 Million to Advance Wearable Biosensors Through Pivotal Trial for Metabolic Health Using Precision Microsensor Technology
Biosensor platform leverages silicon semiconductor manufacturing for scale. Technology designed to provide a better view of metabolic health by combining glucose information with context around activities of daily living in one device. $58 million in funding led by Alpha Wave... Read More →
Eko Health Gains FDA Clearance For Cardiology Algorithm That Can Detect Heart Failure in 15 Seconds
Eko Health received FDA clearance this week for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure. About 6.2 million Americans battle heart failure, with many of them experiencing low ejection fraction,... Read More →
FDA authorizes Prenosis software as first AI tool that can diagnose sepsis
The health technology company Prenosis on Wednesday announced its artificial intelligence-powered diagnostic tool for sepsis is the first to receive approval from the U.S. Food and Drug Administration. Sepsis occurs when the body has an extreme response to an infection, and... Read More →
Neurava raises over $2M to advance life-saving epilepsy monitoring device
INDIANAPOLIS, April 3, 2024 /PRNewswire/ — Neurava announced that it has completed and oversubscribed its Series Seed round, raising $2.26 million. Neurava is developing novel and innovative wearable devices for the estimated 3.5 million Americans and 65 million people worldwide... Read More →
Genetesis Announces Formal Publication of Results from the MAGNETO Trial
Results highlight resting MCG as a rapid, radiation-free alternative to standard of care stress testing for diagnosing myocardial ischemia in acute chest pain patients MASON, Ohio, April 02, 2024–(BUSINESS WIRE)–Genetesis, Inc., a leader in the field of magnetocardiography (MCG), today... Read More →
Photopharmics kickstarts phototherapy trial for Parkinson’s disease
The Celeste phototherapy device uses light to treat symptoms in Parkinson’s patients linked to the circadian system. US-based equipment manufacturer Photopharmics has announced the initiation of its ‘Celeste light for PD’ clinical trial investigating the Celeste phototherapy device. The US... Read More →
Meet the 2024 $200K Challenge Finalists featuring Relavo Medical
Relavo Medical A disinfecting connection device that reduces infection risk associated with dialysis. Read More
FormaPath announces the novel tissue biopsy grossing platform: nToto™
Innovative pathology device developer partnered with leading lab to invent a new, first-in-class product BALTIMORE, March 26, 2024 /PRNewswire/ — In conjunction with a poster presentation at the United States and Canada Association of Pathologists Annual (USCAP) meeting titled “Current... Read More →
Protembis raises $32.6M, adds Shockwave exec to board
Cardiovascular medical device maker Protembis announced today that it completed a $32.6 million (€30 million) Series B financing round. The Aachen, Germany-based company plans to use the funds to support enrollment for its PROTEMBO FDA investigational device exemption (IDE) trial.... Read More →